Dexamethasone as an Adjuvant to Bupivacaine in Supraclavicular Brachial Plexus Block
IFR Journal of Medicine and Surgery · 02.05.2025 · 2 (2) · 13-15
DOI: 10.70146/msv02i02.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift IFR Journal of Medicine and Surgery, erschienen am 02.05.2025. Verfasst von Kago Kanya und 2 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
This study evaluates the efficacy of Dexamethasone as an adjuvant to Bupivacaine when administered in supraclavicular brachial plexus block. A prospective observational study was done with 60 patients divided into two groups: Group A (bupivacaine + saline) and Group B (bupivacaine + dexamethasone). Block characteristics and duration of analgesia were assessed. Group B showed significantly prolonged sensory and motor block duration showing the efficacy of dexamethasone in prolonging the blockade.
Zitieren
APA
Kanya, K., Islam, N., & Das, K. K. (2025). Dexamethasone as an Adjuvant to Bupivacaine in Supraclavicular Brachial Plexus Block. IFR Journal of Medicine and Surgery, 2(2), 13-15. https://doi.org/10.70146/msv02i02.003
Vancouver
Kanya K, Islam N, Das KK. Dexamethasone as an Adjuvant to Bupivacaine in Supraclavicular Brachial Plexus Block. IFR Journal of Medicine and Surgery. 2025;2(2):13-15. doi:10.70146/msv02i02.003
BibTeX
@article{Kanya2025,
author = {Kanya, Kago and Islam, Niviya and Das, Karuna Kumar},
title = {Dexamethasone as an Adjuvant to Bupivacaine in Supraclavicular Brachial Plexus Block},
journal = {IFR Journal of Medicine and Surgery},
year = {2025},
volume = {2},
number = {2},
pages = {13--15},
doi = {10.70146/msv02i02.003}
}
EUVIMED